EUCTR2011-001254-29-ITActive, not recruitingNot Applicable
The Impact of LY2605541 versus Insulin Glargine forPatients with Type 2 Diabetes Mellitus Advanced toMultiple Injection Bolus Insulin with Insulin Lispro: aDouble-Blind, Randomized, 26-Week StudyThe IMAGINE 4 Study - IMAGINE 4
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- ELI LILLY
- Enrollment
- 1,325
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Male or female patients diagnosed with T2DM (for at least 1 year), aged =18 years, with a body mass index =45.0 kg/m2. Patients should have HbA1c value =7.0% to <12.0% at screening; and be taking at least 1 injection of insulin per day with or without OAMs
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 994
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 331
Exclusion Criteria
- •. Patients should not have had any episode of severe hypoglycemia or have had 2 or more emergency room visits/ hospitalizations due to poor glucose control or 1 or more hospitalizations for episodes of ketoacidosis or hyperosmolar state/coma within 6 months prior to Visit 1.
Investigators
Similar Trials
Active, not recruiting
Phase 1
The Impact of LY2605541 versus Insulin Glargine for Patients with Type 1 Diabetes Mellitus Treated with Preprandial Insulin Lispro: an Open-Label, Randomized, 78 week study - IMAGINE 1Type 1 Diabetes MellitusEUCTR2011-001261-40-ITELI LILLY455
Unknown
Phase 3
The Impact of LY2605541 versus Insulin Glargine for Patients with Type 2 Diabetes Mellitus Advanced to Multiple Injection Bolus Insulin with Insulin Lispro: a Double-Blind, Randomized, 26-Week Study (IMAGIN 4)Diabetes Mellitus, Type 2JPRN-jRCT2080221676Eli Lilly Japan K.K.
Completed
Phase 3
The Impact of LY2605541 versus Insulin Glargine for Patients with Type 1 Diabetes Mellitus Treated with Preprandial Insulin Lispro:An Open-Label, Randomized, 78-Week Study (IMAGINE 1)Diabetes Mellitus, Type 1JPRN-jRCT2080221675Eli Lilly Japan K.K.
Active, not recruiting
Not Applicable
A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetesType 2 Diabetes MellitusEUCTR2011-005866-39-DEEli Lilly and Company426
Active, not recruiting
Not Applicable
A Study in Type 2 DiabetesMedDRA version: 14.0Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 DiabetesEUCTR2011-000842-39-ITELI LILLY1,516